Repligen Corporation

NASDAQ:RGEN

139.99 (USD) • At close September 13, 2024
Bedrijfsnaam Repligen Corporation
Symbool RGEN
Munteenheid USD
Prijs 139.99
Beurswaarde 7,840,349,935
Dividendpercentage 0%
52-weken bereik 110.45 - 211.13
Industrie Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Anthony J. Hunt
Website https://www.repligen.com

An error occurred while fetching data.

Over Repligen Corporation

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography

Vergelijkbare Aandelen

DENTSPLY SIRONA Inc. logo

DENTSPLY SIRONA Inc.

XRAY

26.28 USD

Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc.

NBIX

122.25 USD

Exact Sciences Corporation logo

Exact Sciences Corporation

EXAS

65.54 USD

Bruker Corporation logo

Bruker Corporation

BRKR

65.66 USD

Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc.

MRVI

8.39 USD

NovoCure Limited logo

NovoCure Limited

NVCR

18.57 USD

Masimo Corporation logo

Masimo Corporation

MASI

112.8 USD

Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc

JAZZ

108.79 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)